RTGN
RetinalGenix Technologies Inc.
Key Financials
Net Income
$-2428595
↑ 43.8%
Shareholders' Equity
$-2302611.00
↓ 57.4%
Total Assets
$21041.00
↑ 40.8%
Total Liabilities
$2.3M
↑ 57.3%
EPS (Diluted)
$-0.13
↑ 45.8%
Cash & Equivalents
$38.00
0.0%
Operating Cash Flow
$-558350.00
↑ 24.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 6/10/2026 | View on SEC |
| 10-Q | 5/20/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| 10-K | 4/15/2026 | View on SEC |
| NT 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/26/2026 | View on SEC |
| 144 | 2/25/2026 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| 144 | 11/7/2025 | View on SEC |
| 10-Q/A | 8/20/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RTGN |
| Company Name | RetinalGenix Technologies Inc. |
| CIK | 1836295 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 415-578-9583 |